$BCTXL
BriaCell Therapeutics Corp.
Nasdaq · Healthcare · Pharmaceutical Preparations · West Vancouver, British Columbia, Canada
BCTXL chart
What traders are saying about $BCTXL
Latest postsBriaCell Therapeutics Corp. news
- BriaCell Therapeutics Corp. Estimates – NASDAQ:BCTXL
TradingView ·
- BriaCell Therapeutics Corp (TSX:BCT): Why Execution Matters More Than Headlines for Canadian Market Watchers
kalkine.ca ·
- Stocks in play: BriaCell Therapeutics Corp.
Yahoo! Finance Canada ·
- Briacell Therapeutics Corp. Announces Clinical Biomarker Findings from Prospective Pooled Analysis of Patients with Metastatic Breast Cancer Treated with Immune Based Therapies Including the Briacell Regimen
www.marketscreener.com ·
- BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Yahoo Finance ·
- BriaCell Announces ESMO 2026 Poster Highlighting
GlobeNewswire ·
- BriaCell Therapeutics Corp.: What the Latest TSX Market Signals Mean for Investors (TSX:BCT)
kalkine.ca ·
- BriaCell Therapeutics Corp. (TSX:BCT) Gains Bullish Momentum as Cancer Immunotherapy Progress Strengthens Investor Optimism
kalkine.ca ·
- BriaCell Therapeutics Warrant (BCTXZ) Edges Down 2.36% to $0.16 as Price Pins Near $0.15 Support - Outside Reversal
https://www.siam.in/ ·
- BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
Yahoo Finance ·
- Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
Yahoo Finance ·
- BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
Yahoo Finance ·
BriaCell Therapeutics Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$26.3M | -$4.8M | -$20.3M | -$26.8M |
| Diluted EPS | $-62.19 | $-43.68 | $-1.30 | $-1.73 |
| Total assets (year end) | $33.6M | $9.4M | $12.2M | $34.2M |
| Cash and equivalents (year end) | $29.9M | $5.0M | $6.2M | $33.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BriaCell Therapeutics Corp.
- Ticker
- BCTXL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- West Vancouver, British Columbia, Canada
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- July 31
- SEC CIK
- 1610820
- Former names
- Ansell Capital Corp.
Frequently asked questions
What exchange is BriaCell Therapeutics Corp. listed on?
BriaCell Therapeutics Corp. trades on the Nasdaq under the ticker symbol BCTXL.
What industry is BriaCell Therapeutics Corp. in?
BriaCell Therapeutics Corp. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is BriaCell Therapeutics Corp. headquartered?
BriaCell Therapeutics Corp.'s business address on file with the SEC is in West Vancouver, British Columbia, Canada.
When does BriaCell Therapeutics Corp.'s fiscal year end?
BriaCell Therapeutics Corp.'s fiscal year ends on July 31.